Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1986 Jun;61(6):580–584. doi: 10.1136/adc.61.6.580

Hepatitis B virus infection in multitransfused haemophiliacs.

G Nebbia, G A Moroni, L Simoni, M Belli, V Carnelli
PMCID: PMC1777839  PMID: 3089179

Abstract

A longitudinal study of 44 haemophilic children, all in a treatment programme with factor concentrates, was undertaken to evaluate the occurrence, characteristics, and evolution of hepatitis B virus (HBV) infection. Twenty four children (55%) (group I) showed signs of HBV infection, while 20 (45%) (group II) did not. Age at onset of treatment, number of infusions, and total amount of concentrate received did not show significant differences between the two groups. In group I only four children (16%) had symptomatic acute hepatitis. Chronic liver disease was present in nine patients (38% of infected children). The early age of infection would seem to be an important factor for predicting chronic evolution. Evidence of delta infection in three children with severe liver disease seemed to confirm the high pathogenicity of this agent. Because of the risks associated with chronic HBV infection a careful follow up of patients positive for hepatitis B surface antigen is mandatory.

Full text

PDF
580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aledort L. M., Levine P. H., Hilgartner M., Blatt P., Spero J. A., Goldberg J. D., Bianchi L., Desmet V., Scheuer P., Popper H. A study of liver biopsies and liver disease among hemophiliacs. Blood. 1985 Aug;66(2):367–372. [PubMed] [Google Scholar]
  2. Beasley R. P., Hwang L. Y., Lin C. C., Leu M. L., Stevens C. E., Szmuness W., Chen K. P. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982 Aug;146(2):198–204. doi: 10.1093/infdis/146.2.198. [DOI] [PubMed] [Google Scholar]
  3. Bortolotti F., Cadrobbi P., Bertaggia A., Rude L., Alberti A., Realdi G. A 7 year survey of acute hepatitis type B. Arch Dis Child. 1983 Dec;58(12):993–996. doi: 10.1136/adc.58.12.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brownlee G. G., Rizza C. Clotting factor VIII cloned. Nature. 1984 Nov 22;312(5992):307–307. doi: 10.1038/312307a0. [DOI] [PubMed] [Google Scholar]
  5. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  6. Gerety R. J., Eyster M. E., Tabor E., Drucker J. A., Lusch C. J., Prager D., Rice S. A., Bowman H. S. Hepatitis B virus, hepatitis A virus and persistently elevated aminotransferases in hemophiliacs. J Med Virol. 1980;6(2):111–118. doi: 10.1002/jmv.1890060203. [DOI] [PubMed] [Google Scholar]
  7. Gerety R. Removal of hepatitis virus infectivity from clotting factor concentrates. Scand J Haematol Suppl. 1984;40:309–312. doi: 10.1111/j.1600-0609.1984.tb02577.x. [DOI] [PubMed] [Google Scholar]
  8. Gomperts E. D., Lazerson J., Berg D., Lockhart D., Sergis-Deavenport E. Hepatocellular enzyme patterns and hepatitis B virus exposure in multitransfused young and very young hemophilia patients. Am J Hematol. 1981;11(1):55–59. doi: 10.1002/ajh.2830110107. [DOI] [PubMed] [Google Scholar]
  9. Hasiba U., Eyster M. E., Gill F. M., Kajani M., Lewis J. H., Lusch C. J., Prager D., Rice S. A., Shapiro S. S. Liver dysfunction in Pennsylvania's multitransfused hemophiliacs. Dig Dis Sci. 1980 Oct;25(10):776–782. doi: 10.1007/BF01345298. [DOI] [PubMed] [Google Scholar]
  10. Kim H. C., Saidi P., Ackley A. M., Bringelsen K. A., Gocke D. J. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Gastroenterology. 1980 Dec;79(6):1159–1164. [PubMed] [Google Scholar]
  11. Lesesne H. R., Morgan J. E., Blatt P. M., Webster W. P., Roberts H. R. Liver biopsy in hemophilia A. Ann Intern Med. 1977 Jun;86(6):703–707. doi: 10.7326/0003-4819-86-6-703. [DOI] [PubMed] [Google Scholar]
  12. Mannucci P. M., Ronchi G., Rota L., Colombo M. A clinicopathological study of liver disease in haemophiliacs. J Clin Pathol. 1978 Aug;31(8):779–783. doi: 10.1136/jcp.31.8.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ohaki Y., Misugi K., Sasaki Y., Tsunoda A. Hepatitis B surface antigen positive hepatocellular carcinoma in children. Report of a case and review of the literature. Cancer. 1983 Mar 1;51(5):822–828. doi: 10.1002/1097-0142(19830301)51:5<822::aid-cncr2820510513>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  14. Rizzetto M., Morello C., Mannucci P. M., Gocke D. J., Spero J. A., Lewis J. H., Van Thiel D. H., Scaroni C., Peyretti F. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. J Infect Dis. 1982 Jan;145(1):18–22. doi: 10.1093/infdis/145.1.18. [DOI] [PubMed] [Google Scholar]
  15. Rizzetto M., Shih J. W., Gerin J. L. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol. 1980 Jul;125(1):318–324. [PubMed] [Google Scholar]
  16. Scaroni C., Cancellieri V., Carnelli V., Moroni G. A., Angeli M. Addition of hepatitis-B immunoglobulin to clotting factor. Lancet. 1980 Sep 6;2(8193):537–538. [PubMed] [Google Scholar]
  17. Spero J. A., Lewis J. H., Fisher S. E., Hasiba U., Van Thiel D. H. The high risk of chronic liver disease in multitransfused juvenile hemophiliac patients. J Pediatr. 1979 Jun;94(6):875–878. doi: 10.1016/s0022-3476(79)80205-x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES